Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis
References (46)
- et al.
Prevalence of antibody to hepatitis C virus in Italian patients with hepatocellular carcinoma
Lancet
(1989) - et al.
Hepatitis C virus is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis
J Hepatol
(1991) - et al.
A randomized controlled trial with human lymphoblastoid interferon vs no treatment in chronic hepatitis B virus infection. Preliminary results
J Hepatol
(1986) - et al.
Long-term follow-up of chronic hepatitis B patients treated with interferon alfa
Gastroenterology
(1993) - et al.
Long-term follow-up of hepatitis B chronic carriers who responded to interferon therapy
J Hepatol
(1992) - et al.
Long-term response to interferon-alfa 2b retreatment in chronic hepatitis C
J Hepatol
(1994) Hepatocellular carcinoma and hepatitis B virus: evidence for a causal association
Prog Med Virol
(1978)The relation between hepatitis B virus infection and hepatocellular carcinoma
Hepatogastroenterology
(1986)The major etiology of hepatocellular carcinoma
Cancer
(1988)- et al.
Hepatitis B related sequelae. Prospective study in 1400 hepatitis B surface antigen positive Alaska native carriers
Arch Intern Med
(1990)
Primary hepatocellular carcinoma following non-A, non-B posttransfusion hepatitis
Dig Dis Sci
(1983)
Primary hepatocellular carcinoma after chronic non-A, non-B, posttransfusion hepatitis
Ann Intern Med
(1984)
Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study
Ann Intern Med
(1992)
The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. A case controlled study
Cancer
(1992)
Hepatitis B and C viral infections in patients with hepatocellular carcinoma
Hepatology
(1992)
Hepatitis B virus. New and evolving issues
Dig Dis Sci
(1992)
Hepatitis viruses as aetiological agents of hepatocellular carcinoma
Ital J Gastroenterol
(1991)
Risk factors for hepatocellular carcinoma in Italy: male sex, hepatitis B virus, non-A, non-B infection and alcohol
Cancer
(1988)
Pathogenetic factors in cirrhosis with and without hepatocellular carcinoma: a multicenter Italian Study
Hepatology
(1994)
Risk factors for hepatocellular carcinoma in northern Italy
Int J Cancer
(1988)
Assessment of some risk factors for hepatocellular carcinoma: a case control study
Stat Med
(1985)
Risk factors for hepatocellular carcinoma among patients with chronic liver disease
N Engl J Med
(1993)
A large-scale cohort study on risk factors for primary liver cancer, with special reference to the role of cigarette smoking
Cancer Chemother Pharmacol
(1989)
Cited by (314)
Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: A prospective, multicenter study
2013, Journal of HepatologyCitation Excerpt :While recent advances in HCV have led to a markedly improved treatment, HCC is at present the sixth most common cancer and the third cause of cancer death worldwide [4]; moreover, its incidence is increasing due to HCV infection [5]. Previous studies have reported that patients who achieved a sustained virological response (SVR) after interferon (IFN) monotherapy demonstrated improvement in liver fibrosis and a reduction in the incidence of decompensated liver disease and HCC compared with non-SVR patients [6–9]. In the past 10 years, a combination of pegylated IFN (PegIFN) α and ribavirin (RBV) has become the standard treatment and has resulted in an increased SVR rate [10–12].
Causes of and prevention strategies for hepatocellular carcinoma
2012, Seminars in OncologyReview article: immunisation against hepatitis B virus infection and the prevention of hepatocellular carcinoma
2021, Alimentary Pharmacology and TherapeuticsExamining liver cancer patients and a high-risk group in a vulnerable area: An experience from the ulleung liver cancer prevention and management project
2020, International Journal of Environmental Research and Public Health
Copyright © 1996 Published by Elsevier Ireland Ltd.